Skip to main content
Erschienen in: Osteoporosis International 11/2006

01.11.2006 | Original Article

Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey

verfasst von: A. J. Carr, P. W. Thompson, C. Cooper

Erschienen in: Osteoporosis International | Ausgabe 11/2006

Einloggen, um Zugang zu erhalten

Abstract

Objective

To determine the factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis.

Design

Cross-sectional survey.

Setting

National survey in the UK.

Participants

Participants were recruited through the National Osteoporosis Society and advertisements in the press and on the radio and included 533 women over age 50 with osteoporosis who were currently taking or had taken bisphosphonate therapy within the previous 12 months.

Main outcome measures

Self-reported factors influencing adherence and persistence to bisphosphonate therapy in osteoporosis: fracture history, pain, practical difficulties taking medication (frequency of dosing, dealing with comedications, impact on daily routine), perceptions of therapy, and concerns about bisphosphonate therapy.

Results

Adherence to bisphosphonate therapy was 48% and was associated with previous fracture [odds ratio (OR) 1.62, 95% confidence interval (CI) 1.14–3.02], concerns about medication (OR 1.49, 95% CI 1.01–2.20), and less dissatisfaction with medication (OR 0.65, 95% CI 0.44–0.97). Nonpersistence was associated with dissatisfaction with medication (hazard ratio (HR) 1.83, 95% CI 1.38–2.43), side effects (HR 3.69, 95% CI 2.74–4.97), and concerns about bisphosphonate therapy (HR 2.21, 95% CI 1.48–3.30). For both daily (HR 1.53, 95% CI 1.1–2.33) and weekly bisphosphonates (HR 1.90, 95% CI 1.17–3.07), practical difficulties taking bisphosphonate medication—in particular, too frequent dosing—were associated with nonpersistence.

Conclusions

Self-reported nonadherence to daily and weekly bisphosphonates is independent of the decision to stop taking treatment (nonpersistence). Nonpersistence is associated with side effects and other factors that could be modified in clinical practice through education, information, and concordant partnerships.
Literatur
1.
Zurück zum Zitat Caro JJ, Ishak KJ, Huybrechts KF, Raggio G, Naujoks C (2004) The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporosis Int 15:1003–1008CrossRef Caro JJ, Ishak KJ, Huybrechts KF, Raggio G, Naujoks C (2004) The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporosis Int 15:1003–1008CrossRef
2.
Zurück zum Zitat Tosteson AN, Grove MR, Hammond CS et al (2003) Early discontinuation of treatment for osteoporosis. Am J Med 115:209–216PubMedCrossRef Tosteson AN, Grove MR, Hammond CS et al (2003) Early discontinuation of treatment for osteoporosis. Am J Med 115:209–216PubMedCrossRef
3.
Zurück zum Zitat Miller NH (1997) Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med 102:43–49PubMedCrossRef Miller NH (1997) Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med 102:43–49PubMedCrossRef
4.
Zurück zum Zitat Simon JA, Lewiecki EM, Smith ME et al (2002) Patient preference for once-weekly aledronate 70 mg versus once daily aledronate 10 mg: a multicenter, randomised, open label, cross-over study. Clin Ther 24:1871–1886PubMedCrossRef Simon JA, Lewiecki EM, Smith ME et al (2002) Patient preference for once-weekly aledronate 70 mg versus once daily aledronate 10 mg: a multicenter, randomised, open label, cross-over study. Clin Ther 24:1871–1886PubMedCrossRef
5.
Zurück zum Zitat Donovan JL, Blake DR (1992) Patient noncompliance: deviance or reasoned decision-making? Soc Sci Med 34:507–513 Donovan JL, Blake DR (1992) Patient noncompliance: deviance or reasoned decision-making? Soc Sci Med 34:507–513
6.
Zurück zum Zitat Donovan JL, Blake DR, Fleming WG (1989) The patient is not a blank sheet: lay beliefs and their relevance to patient education. Br J Rheumatol 28:58–61 Donovan JL, Blake DR, Fleming WG (1989) The patient is not a blank sheet: lay beliefs and their relevance to patient education. Br J Rheumatol 28:58–61
7.
Zurück zum Zitat Horne R (1999) Patients’ beliefs about treatment: the hidden determinant of treatment outcome? J Psychosom Res 47:491–495 Horne R (1999) Patients’ beliefs about treatment: the hidden determinant of treatment outcome? J Psychosom Res 47:491–495
8.
Zurück zum Zitat Carr AJ, Hughes RA, Vincent K, Carr M, Thwaites C (2004) The impact and implications of new treatments in arthritis: validation of a questionnaire to measure the ‘real life’ effectiveness of medication. Rheumatology 43(suppl):ii83 Carr AJ, Hughes RA, Vincent K, Carr M, Thwaites C (2004) The impact and implications of new treatments in arthritis: validation of a questionnaire to measure the ‘real life’ effectiveness of medication. Rheumatology 43(suppl):ii83
9.
Zurück zum Zitat O’Neill TW, Cooper C, Cannata JB, Diaz Lopez, Hoszowski K et al (1994) Reproducibility of a questionnaire on risk factors for osteoporosis in a multicentre prevalence survey: The European Vertebral Osteoporosis Study. Int J Epidemiology 23(3):559–565 O’Neill TW, Cooper C, Cannata JB, Diaz Lopez, Hoszowski K et al (1994) Reproducibility of a questionnaire on risk factors for osteoporosis in a multicentre prevalence survey: The European Vertebral Osteoporosis Study. Int J Epidemiology 23(3):559–565
10.
Zurück zum Zitat Fletcher RH (1989) Patient compliance with therapeutic advice: a modern view. The Mount Sinai Journal of Medicine 56:453–458 Fletcher RH (1989) Patient compliance with therapeutic advice: a modern view. The Mount Sinai Journal of Medicine 56:453–458
11.
Zurück zum Zitat Kaplan RM, Simon HJ (1990) Compliance in medical care: reconsideration of self-predictions. Annals of Behavioural Medicine 12:66–71 Kaplan RM, Simon HJ (1990) Compliance in medical care: reconsideration of self-predictions. Annals of Behavioural Medicine 12:66–71
12.
Zurück zum Zitat Turbí C, Herrero-Beaumont G, Acebes JC, Torrijos A, Graña J, Miguélez R, Sacristán JA, Marín F (2004) Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective, nonrandomized, observational study. Clin Ther 26:245–256PubMedCrossRef Turbí C, Herrero-Beaumont G, Acebes JC, Torrijos A, Graña J, Miguélez R, Sacristán JA, Marín F (2004) Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective, nonrandomized, observational study. Clin Ther 26:245–256PubMedCrossRef
13.
Zurück zum Zitat Cramer J, Amonkar M, Hebborn A, Suppapanya N (2004) Does dosing regimen impact persistence with bisphosphonate therapy among postmenopausal osteoporotic women? J Bone Miner Res 19(Suppl 1):S448 (Abstract M434) Cramer J, Amonkar M, Hebborn A, Suppapanya N (2004) Does dosing regimen impact persistence with bisphosphonate therapy among postmenopausal osteoporotic women? J Bone Miner Res 19(Suppl 1):S448 (Abstract M434)
14.
Zurück zum Zitat Unson CG, Siccion E, Gaztambide J, Gaztambide S, Mahoney Trella P, Prestwood K (2003) Nonadherence and osteoporosis treatment preferences of older women: a qualitative study. J Women’s Health 12:1037–1045CrossRef Unson CG, Siccion E, Gaztambide J, Gaztambide S, Mahoney Trella P, Prestwood K (2003) Nonadherence and osteoporosis treatment preferences of older women: a qualitative study. J Women’s Health 12:1037–1045CrossRef
15.
Zurück zum Zitat Kendler D, Kung AWC, El-Hajj Fuleihan G, González JGG, Gaines KA, Verbruggen N, Melton ME (2004) Patients with osteoporosis prefer once weekly to once daily dosing with alendronate. Maturitas 48; 243–251PubMedCrossRef Kendler D, Kung AWC, El-Hajj Fuleihan G, González JGG, Gaines KA, Verbruggen N, Melton ME (2004) Patients with osteoporosis prefer once weekly to once daily dosing with alendronate. Maturitas 48; 243–251PubMedCrossRef
16.
Zurück zum Zitat Simon JA, Lewiecki EM, Smith ME, Petruschke RA, Wang L, Palmisano JJ (2002) Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, crossover study. Clin Ther 24:1871–1886PubMedCrossRef Simon JA, Lewiecki EM, Smith ME, Petruschke RA, Wang L, Palmisano JJ (2002) Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, crossover study. Clin Ther 24:1871–1886PubMedCrossRef
17.
Zurück zum Zitat Boccuzzi SJ, Folz SH, Omar MA, Kahler KH (2005) Assessment of adherence and persistence with daily and weekly dosing regimens of oral bisphosphonates. Osteoporosis Int 16(Suppl 4):S35–S36 (Abstract P7.10) Boccuzzi SJ, Folz SH, Omar MA, Kahler KH (2005) Assessment of adherence and persistence with daily and weekly dosing regimens of oral bisphosphonates. Osteoporosis Int 16(Suppl 4):S35–S36 (Abstract P7.10)
18.
Zurück zum Zitat Ettinger MP, Gallagher R, Amonkar M, Smith JC, MacCosbe PE (2004) Medication persistence is improved with less frequent dosing of bisphosphonates, but remains inadequate. Arthritis Rheum 15(Suppl.):S513 (Abstract 1325) Ettinger MP, Gallagher R, Amonkar M, Smith JC, MacCosbe PE (2004) Medication persistence is improved with less frequent dosing of bisphosphonates, but remains inadequate. Arthritis Rheum 15(Suppl.):S513 (Abstract 1325)
Metadaten
Titel
Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey
verfasst von
A. J. Carr
P. W. Thompson
C. Cooper
Publikationsdatum
01.11.2006
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 11/2006
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-006-0166-2

Weitere Artikel der Ausgabe 11/2006

Osteoporosis International 11/2006 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TEP mit Roboterhilfe führt nicht zu größerer Zufriedenheit

15.05.2024 Knie-TEP Nachrichten

Der Einsatz von Operationsrobotern für den Einbau von Totalendoprothesen des Kniegelenks hat die Präzision der Eingriffe erhöht. Für die postoperative Zufriedenheit der Patienten scheint das aber unerheblich zu sein, wie eine Studie zeigt.

Lever-Sign-Test hilft beim Verdacht auf Kreuzbandriss

15.05.2024 Vordere Kreuzbandruptur Nachrichten

Mit dem Hebelzeichen-Test lässt sich offenbar recht zuverlässig feststellen, ob ein vorderes Kreuzband gerissen ist. In einer Metaanalyse war die Vorhersagekraft vor allem bei positivem Testergebnis hoch.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.